 Cellectar Biosciences Inc NASDAQ: CLRB shares are trading higher by 12.1 at 0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated earnings by 10.0, reporting an EPS loss of 9 cents versus an estimate of a. 